MGLIX | NMMGX | MGLIX / NMMGX | |
Total Expense Ratio | 0.94 | 0.93 | 101% |
Annual Report Gross Expense Ratio | 0.95 | 1.09 | 87% |
Fund Existence | 16 years | 17 years | - |
Gain YTD | -0.187 | 2.610 | -7% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.28B | 93.5M | 2,437% |
Annual Yield % from dividends | 2.60 | 2.41 | 108% |
Returns for 1 year | 0.29 | 4.44 | 6% |
Returns for 3 years | -8.44 | -0.18 | 4,788% |
Returns for 5 years | 20.96 | 28.16 | 74% |
Returns for 10 years | 23.99 | -13.75 | -175% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSCHX | 12.77 | N/A | N/A |
Fidelity Select Chemicals | |||
FGEAX | 25.23 | N/A | N/A |
Fidelity Advisor Glbl Capital Apprec A | |||
JACJX | 18.53 | N/A | N/A |
JHancock Mid Cap Growth A | |||
JFNNX | 63.95 | -1.31 | -2.01% |
Janus Henderson Global Life Sciences N | |||
GQSCX | 12.62 | -0.37 | -2.85% |
Glenmede Disciplined US Small Cap Eq Ptf |